Leading Medical Supply Company Medical Home Products Attains Profitability
Posted on: Monday, 6 February 2006, 09:01 CST
Medical Home Products, Inc. (Pink Sheets:MHPT) (http://www.medicalhomeproducts.com) today announced that it has achieved profitability during the month of January 2006.
Paul Mathis, President and CEO, commented, "The Company is continuing its current trend of expanding our product offerings and focusing our advertising efforts, particularly in the drug testing and cholesterol testing areas. By doing so, we expand and complement our existing product lines and increase our satisfied customers. Medical Home Products continues to market its products on eBay, Amazon.com and through Independent distributor affiliate programs worldwide."
About Medical Home Products
Medical Home Products, Inc. an International resale provider of over 200 self-test medical kits sold via the internet and direct sales. Medical Home Products differentiates itself in the 2.82 Billion Dollar US self-test kit market by selling a comprehensive line of cross selection medical self-test kits for diabetes, cholesterol, fertility, pregnancy, HIV, thyroid, prostate, drug and alcohol.
Medical Home Products operates a direct sales and virtual network to the worldwide home medical market, organized clinics and drug rehab facilities.
Safe Harbor
This Press Release contains forward-looking statements that may include statements without limitation, regarding intent, belief or current expectations of the Company and its management. Actual results could differ materially from those anticipated in the forward looking statements as a result of a number of important factors, including regulatory actions, competition, adverse economic changes affecting markets we serve and management of growth. For a discussion of these and other risks and uncertainties that could affect the Company's activities and results, please refer to the Company's filings. Medical Home Products takes no obligation to update or correct forward-looking statements.
Source: Business Wire
Related Articles
- Power3 Medical Products in Talks With Industry Leaders to License and Market Its Proprietary Technology for Diagnostic, Disease Detection Blood Tests for Breast Cancer, Alzheimer's and Parkinson's Disease
- Power3 Medical Products to Market Diagnostic Tests
- Power3 Medical Products, Inc. Makes Its Diagnostic Tests Ready for Commercialization
- Power3 Medical Products Announces New Collaboration for Breast Cancer Test
- Power3 Medical Products and the Princess Haya Biotechnology Center, Jordan University of Science and Technology, Collaborate in a Clinical Validation Study of the BC-SeraPro(TM) Breast Cancer Diagnostic Blood Test
- Power3 Medical Products, Inc. Launches BC-SeraPro, the First Proteomics-Based Blood Serum Diagnostic Test for Breast Cancer
- Power3 Medical Products, Inc. Announces Preliminary International Validation Results of Their Blood Serum Biomarker Test for Parkinson's Diseases
- D-Link Has Fastest Draft 802.11n Wireless Products on Market, Test Studies Show*
- Power3 Medical Files Application With U.S. Patent Office for Test to Determine Resistance to Gleevec, a Leading Leukemia Drug; Power3 Also Offers Design Specifications to Overcome Resistance to Drug
- European Committee for Orphan Medical Products Recommends Orphan Drug Status for AmpliMed's Amplimexon for Pancreatic Cancer
 |
 |
User Comments (0)
RSS Feeds